Wegovy 1mg prefilled injectable, manufactured by Novo Nordisk, is a prescription-only treatment that serves as a powerful tool in the battle against obesity, especially for individuals at risk of developing diabetes or those already diagnosed with Type 2 Diabetes. This innovative medication is designed to be used in conjunction with a carefully monitored calorie-controlled diet and an increased exercise regimen. It offers hope for those struggling with excess weight, providing a pathway to significant and sustainable weight loss.
Wegovy 1mg prefilled injectable is a prescription-only treatment for:
- Those at risk of Diabetes
- Type 2 Diabetes.
What Does Wegovy Do?
Containing Semaglutide (similar to a natural hormone called Glucagon-like Peptide-1 which is released in the intestine after eating), Wegovy 1ml interacts with the brain to make you feel fuller for longer, with less cravings. When combined with a calorie deficit lifestyle, Wegovy 1mg has shown an increase in weight loss of between 5%-20% than those on a calorie-deficit lifestyle alone.
Individuals can not only shed excess pounds but also reduce their risk of diabetes-related complications. For those with Type 2 Diabetes, Wegovy 1mg contributes to improved blood sugar control while promoting a healthier body weight.
Novo Nordisk has offered a promising tool to address the intertwined challenges of obesity and diabetes, empowering individuals to take control of their health and well-being.
For further information regarding Wegovy 1mg and Semaglutide including risks and side effects, visit Novomedlink.
4mg Semaglutide in 3ml, disodium phosphate dihydrate, propylene glycol, phenol, hydrochloric acid/sodium hydroxide (for PH adjustment), water for injection
Each Pack Contains
- 1 x Prefilled Pen
- 4 x Disposable Needles